Breaking News Instant updates and real-time market news.

NUS

Nu Skin

$45.50

1.44 (3.27%)

17:03
07/16/19
07/16
17:03
07/16/19
17:03

Nu Skin cuts Q2 EPS view to 82c-84c from 91c-98c, consensus 94c

Cuts Q2 revenue view to $622M-$623M from $660M-$680M, consensus $673.95M. CEO Ritch Wood says: "We are adjusting our guidance for the year primarily due to a reduced revenue outlook in Mainland China following the government's 100-day campaign to review and inspect the health products and direct selling industries. Continued restrictions on sales meetings, as well as media scrutiny, have negatively impacted consumer sentiment and contributed to this adjustment. While we anticipated we could begin holding meetings in the second quarter, meeting approvals for the industry have been significantly more restrictive than expected and remain limited. Additionally, the U.S. dollar has continued to strengthen, and we have adjusted our 2019 guidance to include a larger-than-anticipated foreign currency impact. We will provide more detail regarding results for the second quarter in our earnings release scheduled for Aug. 6."

NUS Nu Skin
$45.50

1.44 (3.27%)

04/03/19
STFL
04/03/19
NO CHANGE
Target $43
STFL
Sell
Stifel reiterates Sell rating on Nu Skin after Usana profit warning
After Usana (USNA) announced softer than expected preliminary Q1 results, which it attributed to sales in China and unfavorable media coverage on the direct selling industry there, Stifel analyst Mark Astrachan reiterated his Sell rating and $43 price target on shares of competitor Nu Skin (NUS). Despite Nu Skin having less exposure to nutrition than Usana, Astrachan continues to worry about increasing scrutiny on Nu Skin and thinks the potential for a more thorough investigation by the Chinese government remains a risk.
05/01/19
DBAB
05/01/19
UPGRADE
DBAB
Buy
Nu Skin upgraded to Buy from Hold at Deutsche Bank
05/01/19
DBAB
05/01/19
UPGRADE
Target $73
DBAB
Buy
Deutsche Bank upgrades Nu Skin to Buy on reduced China risk
Deutsche Bank analyst Faiza Alwy upgraded Nu Skin Enterprises to Buy from Hold and raised her price target for the shares to $73 from $64. The analyst sees "materially" lower China risk following the company's Q1 results. Despite having to limit certain business meetings in China for at least a 100-day period while the regulatory authorities conducted an industry-wide investigation regarding product claims, Nu Skin delivered 12% Mainland China sales growth, Alwy tells investors in a post-earnings research note.
07/03/19
STFL
07/03/19
NO CHANGE
Target $45
STFL
Sell
Stifel keeps Sell on Nu Skin after Usana cuts outlook on China
Nu Skin Enterprises (NUS) competitor Usana last night announced preliminary Q2 results with sales 17% below consensus and the company also lowered full year sales and earnings guidance 16% and 25%, respectively, at the midpoint, Stifel analyst Mark Astrachan tells investors in a research note. Usana's downside is largely due to softer than expected sales in China, which the company expects will continue throughout 2019, the analyst adds. He points out that increased promotional activity in China did not generate meaningful sales and customer growth. Astrachan says this is consistent with the risks noted in his downgrade of Nu Skin shares to Sell. The analyst is now more cautious on China and keeps a Sell rating on Nu Skin shares with a $45 price target.

TODAY'S FREE FLY STORIES

UVXY

ProShares Trust Ultra VIX Short Term Futures ETF

$31.70

-2.48 (-7.26%)

09:47
08/19/19
08/19
09:47
08/19/19
09:47
Hot Stocks
ProShares Trust Ultra VIX Short Term Futures ETF falls -7.2% »

ProShares Trust Ultra VIX…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JNUG

Direxion Daily Jr Gld Mnrs Bull 3X Shrs

$71.82

-6.26 (-8.02%)

09:47
08/19/19
08/19
09:47
08/19/19
09:47
Hot Stocks
Direxion Daily Jr Gld Mnrs Bull 3X Shrs falls -7.9% »

Direxion Daily Jr Gld…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PCG

PG&E

$10.40

-3.9 (-27.27%)

09:47
08/19/19
08/19
09:47
08/19/19
09:47
Hot Stocks
PG&E falls -27.3% »

PG&E is down -27.3%,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EL

Estee Lauder

$198.05

18.785 (10.48%)

09:47
08/19/19
08/19
09:47
08/19/19
09:47
Hot Stocks
Estee Lauder rises 10.4% »

Estee Lauder is up 10.4%,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Aug

TGNA

Tegna

$16.42

1.34 (8.89%)

09:47
08/19/19
08/19
09:47
08/19/19
09:47
Hot Stocks
Tegna rises 9.4% »

Tegna is up 9.4%, or…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Sep

ARMK

Aramark

$41.24

4.17 (11.25%)

09:47
08/19/19
08/19
09:47
08/19/19
09:47
Hot Stocks
Aramark rises 11.2% »

Aramark is up 11.2%, or…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PCG

PG&E

$14.30

(0.00%)

09:43
08/19/19
08/19
09:43
08/19/19
09:43
Downgrade
PG&E rating change  »

PG&E downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WB

Weibo

$37.05

(0.00%)

, IQ

iQIYI

$17.08

(0.00%)

09:40
08/19/19
08/19
09:40
08/19/19
09:40
Options
Unusually active option classes on open August 19th »

Unusual total active…

WB

Weibo

$37.05

(0.00%)

IQ

iQIYI

$17.08

(0.00%)

LYFT

Lyft

$52.37

(0.00%)

XLU

Utilities SPDR

$61.35

(0.00%)

UAL

United Continental

$82.96

(0.00%)

WYNN

Wynn Resorts

$105.58

(0.00%)

EA

Electronic Arts

$89.56

(0.00%)

DB

Deutsche Bank

$6.95

(0.00%)

NVDA

Nvidia

$159.48

(0.00%)

MSFT

Microsoft

$136.13

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Aug

  • 19

    Aug

  • 19

    Aug

  • 20

    Aug

  • 04

    Sep

  • 04

    Sep

  • 05

    Sep

  • 09

    Sep

  • 10

    Sep

  • 23

    Sep

  • 27

    Oct

  • 13

    Nov

OMCL

Omnicell

$70.48

0.475 (0.68%)

09:38
08/19/19
08/19
09:38
08/19/19
09:38
Conference/Events
Omnicell management to meet with Benchmark »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Sep

CHU

China Unicom

$9.93

0.155 (1.59%)

09:35
08/19/19
08/19
09:35
08/19/19
09:35
Downgrade
China Unicom rating change  »

China Unicom downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

09:35
08/19/19
08/19
09:35
08/19/19
09:35
General news
FX Action: USD-CAD »

FX Action: USD-CAD pulled…

REDU

Rise Education

$7.88

-0.13 (-1.62%)

09:34
08/19/19
08/19
09:34
08/19/19
09:34
Downgrade
Rise Education rating change  »

Rise Education downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TGNA

Tegna

$15.08

1.465 (10.76%)

09:31
08/19/19
08/19
09:31
08/19/19
09:31
Upgrade
Tegna rating change  »

Tegna upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Sep

CLNC

Colony Credit Real Estate

$13.04

0.165 (1.28%)

09:31
08/19/19
08/19
09:31
08/19/19
09:31
Recommendations
Colony Credit Real Estate analyst commentary  »

Colony Credit Real Estate…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ZS

Zscaler

$80.84

1.67 (2.11%)

09:30
08/19/19
08/19
09:30
08/19/19
09:30
Downgrade
Zscaler rating change  »

Zscaler downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Sep

  • 10

    Oct

  • 15

    Oct

LGF.A

Lionsgate

$11.06

0.02 (0.18%)

, LGF.B

Lionsgate

$10.52

0.01 (0.10%)

09:30
08/19/19
08/19
09:30
08/19/19
09:30
Upgrade
Lionsgate, Lionsgate rating change  »

Lionsgate upgraded to…

LGF.A

Lionsgate

$11.06

0.02 (0.18%)

LGF.B

Lionsgate

$10.52

0.01 (0.10%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PANW

Palo Alto Networks

$199.26

-15.5 (-7.22%)

09:29
08/19/19
08/19
09:29
08/19/19
09:29
Recommendations
Palo Alto Networks analyst commentary  »

Palo Alto Networks…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Sep

  • 10

    Sep

  • 10

    Oct

  • 15

    Oct

PULM

Pulmatrix

$0.82

0.0076 (0.94%)

09:28
08/19/19
08/19
09:28
08/19/19
09:28
Hot Stocks
Pulmatrix receives U.S. patent covering iSPERSE formulations »

Pulmatrix has received a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Sep

MMSI

Merit Medical

$36.17

-0.67 (-1.82%)

09:27
08/19/19
08/19
09:27
08/19/19
09:27
Hot Stocks
Merit Medical appoints Lynne Ward to board of directors »

Merit Medical Systems…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Sep

  • 05

    Sep

VMW

VMware

$143.67

1.13 (0.79%)

, AMZN

Amazon.com

$1,791.82

16.72 (0.94%)

09:27
08/19/19
08/19
09:27
08/19/19
09:27
Recommendations
VMware, Amazon.com, Microsoft analyst commentary  »

VMware to deliver…

VMW

VMware

$143.67

1.13 (0.79%)

AMZN

Amazon.com

$1,791.82

16.72 (0.94%)

MSFT

Microsoft

$136.13

2.39 (1.79%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Aug

  • 04

    Sep

  • 10

    Sep

  • 10

    Oct

  • 27

    Oct

VCEL

Vericel

$16.31

0.705 (4.52%)

09:25
08/19/19
08/19
09:25
08/19/19
09:25
Conference/Events
Vericel participates in a conference call with SVB Leerink »

SVB Leerink to host a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Aug

RNVA

Rennova Health

$0.00

(0.00%)

09:22
08/19/19
08/19
09:22
08/19/19
09:22
Hot Stocks
Rennova receives CMS notice on change in ownership for Jellico Medical Center »

Rennova Health announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PANW

Palo Alto Networks

$199.26

-15.5 (-7.22%)

09:20
08/19/19
08/19
09:20
08/19/19
09:20
Recommendations
Palo Alto Networks analyst commentary  »

Palo Alto Networks…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Sep

  • 10

    Sep

  • 10

    Oct

  • 15

    Oct

HZNP

Horizon Pharma

$27.00

0.17 (0.63%)

09:19
08/19/19
08/19
09:19
08/19/19
09:19
Hot Stocks
AJO review says Horizon Pharma's teprotumumab could potentially treat TED »

An evaluation of the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Sep

  • 18

    Sep

NXRT

NexPoint Residential

$44.85

0.9 (2.05%)

09:19
08/19/19
08/19
09:19
08/19/19
09:19
Recommendations
NexPoint Residential analyst commentary  »

NexPoint Residential…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.